Halogenated spirotetronates from Actinoallomurus

Journal of Natural Products

Volumn 75, Issue 6, 2012, Pages 1044-1050

  Mazzetti, Carlo ^a,b   Ornaghi, Mirko ^a   Gaspari, Eleonora ^a   Parapini, Silvia ^c   Maffioli, Sonia ^a   Sosio, Margherita ^a   Donadio, Stefano ^a  

^a NAICONS Srl   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROMIDE ION; CHLORIDE ION; HALOGENATED SPIROTETRONATE DERIVATIVE; NAI 414 A; NAI 414 B; NAI 414 C; NAI 414 D; TETRONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; HALOGENATED HYDROCARBON; NAI414 A; NAI414 B; NAI414-A; NAI414-B; SPIRO COMPOUND;

ACTINOALLOMURUS; ACTINOBACTERIA; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; STRUCTURE ANALYSIS; ACTINOMYCETALES; CANDIDA ALBICANS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENDOTHELIUM CELL; GRAM POSITIVE BACTERIUM; ISOLATION AND PURIFICATION; MACROPHAGE; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE; STREPTOCOCCUS PNEUMONIAE;

POSIBACTERIA;

ACTINOMYCETALES; ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; ENDOTHELIAL CELLS; GRAM-POSITIVE BACTERIA; HUMANS; HYDROCARBONS, HALOGENATED; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SPIRO COMPOUNDS; STREPTOCOCCUS PNEUMONIAE;

EID: 84866441159     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np300003n     Document Type: Article

References (18)

1. (a) Lam, K. S.; Hesler, G. A.; Gustavson, D. R.; Berry, R. L.; Tomita, K.; Macbeth, J. L.; Ross, J.; Miller, D.; Forenza, S. J. Antibiot. 1996, 49, 860-864.
2. (b) Tomita, F.; Tamaoki, T. J. Antibiot. 1980, 33, 940-945.
3. (a) Nakashima, T.; Miura, M.; Hara, M. Cancer Res. 2000, 60, 1229-1235.
4. (b) Anether, G.; Tinholfer, I.; Senfter, M.; Greil, R. Blood 2003, 101, 4561-4568.
5. (c) Tamaoki, T.; Kasai, M.; Shirahata, K.; Ohkubo, S.; Morimoto, M.; Mineura, K.; Ishii, S.; Tomita, F. J. Antibiot. 1980, 33, 946-950.
6. Kawashima, A.; Nakamura, Y.; Ohta, Y.; Akama, T.; Yamagishi, M.; Hanada, K. J. Antibiot. 1992, 45, 207-212.
7. Pozzi, R.; Simone, M.; Mazzetti, C.; Maffioli, S.; Monciardini, P.; Cavaletti, L.; Bamonte, R.; Sosio, M.; Donadio, S. J. Antibiot. 2011, 64, 133-139.
8. Tamura, T.; Ishida, Y.; Nozawa, Y.; Otoguro, M.; Suzuki, K. Int. J. Syst. Evol. Microbiol. 2009, 59, 1867-1874.
9. Momose, I.; Hirosawa, S.; Nakamura, H.; Naganawa, H.; Iinuma, H.; Ikeda, D.; Takeuchi, T J. Antibiot. 1999, 52, 787-796.
10. Schroeder, D. R.; Colson, K. L.; Klohr, S. E.; Mike, S. L.; Matson, J. A. J. Antibiot. 1996, 49, 865-872.
11. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092-4096.
12. (a) Holzer, M.; Burd, W.; Reibig, H. U.; van Pée, K. H. Adv. Synth. Catal. 2001, 343, 591-595.
13. (b) Lang, A.; Polnick, S.; Nicke, T.; William, P.; Patallo, E. P.; Naismith, J. H.; van Pée, K. H. Angew. Chem., Int. Ed. 2011, 50, 2951-2953.
14. (c) Clark, B. R.; Murphy, C. D. Org. Biomol. Chem. 2009, 7, 111-116.
15. Thomas, G. M.; Burkart, M. D.; Walsh, C. T. Chem. Biol. 2002, 9, 171-184.
16. Dorrestein, P. C.; Yeh, E.; Garneau-Tsodikova, S.; Kelleher, N. L.; Walsh, C. T. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 13843-13848.
17. National Committee for Clinical Laboratory Standards, 7th ed.; Approved Standards, NCCLS document M7-A7; NCCLS: Wayne, PA, 2006.
18. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.